跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Eversil - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Eversil
Approved
STANDARD
Eversil
Apex Laboratories Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7c119ae0019b1de6
Company
Apex Laboratories Private Limited
Type
Standard
Approval Details
Approval Id
7c119ae0019b1de6
Drug Approval Philippines Name
Eversil
Product Name
Eversil
Registration Number
DR-XY44729
Brand Name
Eversil
Generic Name
Silver Sulfdiazine
Dosage Form
Cream
Dosage Strength
10mg (1% w/w)
Manufacturer
Apex Laboratories Private Limited
Importer
Xeno Pharmaceuticals Phils. Inc.
Distributor
Xeno Pharmaceuticals Phils. Inc.
Company Detail Path
/organization/apex-laboratories-private-limited
Issuance Date
28 September 2020
Expiry Date
03 August 2025
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7c119ae0019b1de6
Type
Standard
Back to Philippines FDA Approvals